Shizuoka, Japan

Emiko Suzuki

This inventor holds 2 USPTO granted patents and 1 published patent application and 4 EPO patents. Top assignees: Hitachi Chemical Diagnostics Systems Co., Ltd., Kyowa Medex Co., Ltd.. Active years: 2019-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Emiko Suzuki. Retrieved from https://idiyas.com/inventor/emiko-suzuki-1zfk1os2

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2019-2024

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Emiko Suzuki: Innovator in Fibroblast Growth Factor Measurement

Introduction

Emiko Suzuki is a prominent inventor based in Shizuoka, Japan. She has made significant contributions to the field of medical diagnostics, particularly in the measurement of fibroblast growth factor-23 (FGF-23). With a total of 2 patents to her name, her work has the potential to enhance the accuracy and sensitivity of diagnostic tests.

Latest Patents

Emiko Suzuki's latest patents focus on a method for measuring fibroblast growth factor-23. This innovative method provides a high sensitivity and a wide measurement range for FGF-23 in various samples. The invention outlines specific steps to ensure accurate measurement, which is crucial for diagnosing related health conditions.

Career Highlights

Throughout her career, Emiko has worked with notable companies such as Hitachi Chemical Diagnostics Systems Co., Ltd. and Kyowa Medex Co., Ltd. Her experience in these organizations has allowed her to develop and refine her innovative methods in medical diagnostics.

Collaborations

Emiko has collaborated with talented individuals in her field, including Kazuki Morita and Koji Uzawa. These partnerships have contributed to her success and the advancement of her research.

Conclusion

Emiko Suzuki is a trailblazer in the field of fibroblast growth factor measurement, with her innovative methods poised to make a significant impact in medical diagnostics. Her contributions reflect her dedication to improving healthcare through technology and innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…